glp-1 receptor agonist mechanism of action Trends in the Development Agonists The Potential Role of GLP-1

Description

Pharmacologic Treatment of Overweight and Obesity in Adults (MDText.com, 2021)

In addition to aforementioned properties of GLP-1 agonists, it can also reduce hypertension by activating and phosphorylating endothelial nitric oxide synthase pathways, thus increasing the bioavailability of nitric oxide which promotes vasodilation

In STEP-1 (semaglutide), lean mass decreased by ~9.7% while fat mass fell by ~19.3%, with the proportion of lean mass increasing by ~3 percentage points ( Limited preclinical and clinical data, particularly from MRI-based studies, suggest that skeletal muscle changes induced by GLP-1RAs may be adaptive

It stimulates your pancreas to release insulin, which lowers blood sugar after meals, and suppresses glucagon, which would otherwise raise blood sugar

Currently, intense media attention and influencer promotion, coupled with robust marketing tactics, have led to an increase in the demand for GLP-1 RAs, resulting in global shortages of these medications